Human Molecular Genetics Advance Access published online on June 15, 2006
Human Molecular Genetics, doi:10.1093/hmg/ddl149
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Queensland Institute of Medical Research, Radiation Biology and Oncology Laboratory, Brisbane, Queensland 4029, Australia
* To whom correspondence should be addressed. The APTX gene mutated in patients with the neurological disorder ataxia with oculomotor apraxia type 1 (AOA1) encodes a novel protein aprataxin. We describe here, the interaction and interdependence between aprataxin and several nucleolar proteins, including nucleolin, nucleophosmin and upstream binding factor-1 (UBF-1), involved in ribosomal RNA synthesis and cellular stress signalling. Interaction between aprataxin and nucleolin occurred through their respective N-terminal regions. In AOA1 cells lacking aprataxin the stability of nucleolin was significantly reduced. On the other hand down-regulation of nucleolin by RNA interference did not affect aprataxin protein levels but abolished its nucleolar localisation suggesting that the interaction with nucleolin is involved in its nucleolar targeting. GFP-aprataxin fusion protein co-localized with nucleolin, nucleophosmin and UBF-1 in nucleoli and inhibition of ribosomal DNA transcription altered the distribution of aprataxin in the nucleolus, suggesting that the nature of the nucleolar localization of aprataxin is also dependent on ongoing ribosomal RNA (rRNA) synthesis. In vivo rRNA synthesis analysis showed only a minor decrease in AOA1 cells compared to controls cells. These results demonstrate a cross-dependence between aprataxin and nucleolin in the nucleolus and while aprataxin does not appear to be directly involved in rRNA synthesis its nucleolar localization is dependent on this synthesis.
Received March 22, 2006
Revised June 3, 2006
Accepted June 3, 2006
Article
Nucleolar localization of Aprataxin is dependent on interaction with nucleolin and on active ribosomal DNA transcription
Olivier J. Becherel 1,
Nuri Gueven 1,
Geoff W. Birrell 1,
Valeérie Schreiber 2,
Amila Suraweera 1,
Burkhard Jakob 3,
Gisela Taucher-Scholz 3,
and
Martin F. Lavin 4 *
2 Département Intégrité du Génôme de l'UMR 7175, CNRS, Ecole Supérieure de Biotechnologie de Strasbourg, Boulevard Sébastien Brant, BP 10413, F-67412 Illkirch Cedex, France
3 Gesellschaft für Schwerionenforschung mBH, Planckstr. 1, 64291 Darmstadt, Germany
4 Queensland Institute of Medical Research, Radiation Biology and Oncology Laboratory, Brisbane, Queensland 4029, Australia; Central Clinical Divison, University of Queensland, Brisbane, Australia
Martin F. Lavin, E-mail: martinL{at}qimr.edu.au
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. L. Harris, B. Jakob, G. Taucher-Scholz, G. L. Dianov, O. J. Becherel, and M. F. Lavin Aprataxin, poly-ADP ribose polymerase 1 (PARP-1) and apurinic endonuclease 1 (APE1) function together to protect the genome against oxidative damage Hum. Mol. Genet., November 1, 2009; 18(21): 4102 - 4117. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suraweera, Y. Lim, R. Woods, G. W. Birrell, T. Nasim, O. J. Becherel, and M. F. Lavin Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation Hum. Mol. Genet., September 15, 2009; 18(18): 3384 - 3396. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suraweera, O. J. Becherel, P. Chen, N. Rundle, R. Woods, J. Nakamura, M. Gatei, C. Criscuolo, A. Filla, L. Chessa, et al. Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage J. Cell Biol., July 30, 2007; 177(6): 969 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ma, S. Matsunaga, H. Takata, R. Ono-Maniwa, S. Uchiyama, and K. Fukui Nucleolin functions in nucleolus formation and chromosome congression J. Cell Sci., June 15, 2007; 120(12): 2091 - 2105. [Abstract] [Full Text] [PDF] |
||||


